Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akoya BioSciences, Inc. - Common Stock (NQ:AKYA)

1.220 +0.010 (+0.83%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 212,616
Open 1.190
Bid (Size) 1.210 (7)
Ask (Size) 1.750 (20)
Prev. Close 1.210
Today's Range 1.190 - 1.270
52wk Range 1.010 - 4.650
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Quanterix and Akoya Biosciences Announce Amended Merger Agreement
From Quanterix Corporation
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PPBI, SSBK, AKYA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire

Performance

YTD
-49.8%
-49.8%
1 Month
+5.6%
+5.6%
3 Month
-55.5%
-55.5%
6 Month
-53.4%
-53.4%
1 Year
-70.4%
-70.4%

More News

Read More
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Pacific Premier Bancorp, Inc. (Nasdaq - PPBI), Southern States Bancshares, Inc. (Nasdaq - SSBK), Akoya Biosciences, Inc. (Nasdaq - AKYA)
From Brodsky & Smith LLC
Via GlobeNewswire
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
From Akoya Biosciences, Inc.
Via GlobeNewswire
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas
From Akoya Biosciences, Inc.
Via GlobeNewswire
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore
From Akoya Biosciences, Inc.
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, SLRN, AKYA, SHYF on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
From Akoya Biosciences, Inc.
Via GlobeNewswire
This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
This Brown & Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
From Akoya Biosciences, Inc.
Via GlobeNewswire
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
From Akoya Biosciences, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
From Kahn Swick & Foti, LLC
Via Business Wire
Shareholder Alert: Ademi LLP Investigates Whether Akoya Biosciences, Inc. Is Obtaining a Fair Price for Its Public Shareholders
From Ademi LLP
Via Business Wire
AKYA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akoya Biosciences, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers
From Quanterix Corporation
Via Business Wire
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
From Akoya Biosciences, Inc.
Via GlobeNewswire
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone
From Akoya Biosciences, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Akoya Biosciences Reports Third Quarter 2024 Financial Results
From Akoya Biosciences, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Akoya BioSciences, Inc. - Common Stock publicly traded?
Yes, Akoya BioSciences, Inc. - Common Stock is publicly traded.
What exchange does Akoya BioSciences, Inc. - Common Stock trade on?
Akoya BioSciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Akoya BioSciences, Inc. - Common Stock?
The ticker symbol for Akoya BioSciences, Inc. - Common Stock is AKYA on the Nasdaq Stock Market
What is the current price of Akoya BioSciences, Inc. - Common Stock?
The current price of Akoya BioSciences, Inc. - Common Stock is 1.220
When was Akoya BioSciences, Inc. - Common Stock last traded?
The last trade of Akoya BioSciences, Inc. - Common Stock was at 05/02/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.